AN OPEN, MULTICENTER, RANDOMIZED, DOSE-RANGING STUDY OF AZITHROMYCIN IN THE TREATMENT OF DISSEMINATED MYCOBACTERIUM AVIUM-INTRACELLULARE COMPLEX INFECTION (MAC) IN PATIENTS WITH ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS):